News

Filter

Current filters:

Oncology

1 to 9 of 2728 results

Eisai and Merck enter cancer research collaboration

05-03-2015

Japanese drug major Eisai saw its shares gain 7.15% to 6,732 yen after it announced it had entered into…

EisaiHalavenKeytrudaLenvimaMerck & CoOncologyPharmaceuticalResearch

Norgine partners with Navidea for Lymphoseek marketing in Europe

05-03-2015

Netherlands-headquartered independent drugmaker Norgine says that its affiliate, SpePharm AG, has entered…

BiotechnologyEuropeLicensingLymphoseekNavidea BiopharmaceuticalsNorgineOncology

US FDA expands use of Bristol-Myers’ Opdivo to NSCLC

US FDA expands use of Bristol-Myers’ Opdivo to NSCLC

05-03-2015

The US Food and Drug Administration late yesterday expanded the approved use of pharma major Bristol-Myers…

BiotechnologyBristol-Myers SquibbOncologyOpdivoRegulationUSA

Novogen’s TRXE-009 kills brain cancer stem cells

Novogen’s TRXE-009 kills brain cancer stem cells

05-03-2015

Shares of Australian biotech company Novogen rose dramatically as it announced that one of its lead candidate…

AustraliaBiotechnologyNovogenOncologyResearch

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

04-03-2015

Clinical-stage biopharma company arGEN-X has exercised its option to exclusively license preclinical…

arGEN-XBelgiumBiotechnologyLicensingOncology

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

04-03-2015

Analysts at Morningstar Equity Research see significantly more opportunity than the overall market for…

AstraZenecaBiotechnologyBristol-Myers SquibbMarkets & MarketingMerck & CoOncologyOpdivoResearchRoche

1 to 9 of 2728 results

COMPANY SPOTLIGHT

Menarini

Back to top